Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New ways of looking at viruses

This article was originally published in Scrip

Executive Summary

Traditional methods of attacking viruses are based on their biological characteristics. For example, immunisation involves either exposing the patient to an antigen that can induce antibodies against the virus in question, or directly administering antibodies that have been obtained from a patient who has recovered from the infection, or perhaps have been raised in an animal. Antiviral drugs act by interfering with the biological processes in the virus, such as by inhibiting an enzyme that occurs in the virus but not in the host.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC006811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel